Politics
Transparency groups warn half of EU drug trial results not fully disclosed
Around 20% of trials published incomplete findings
This story was reported by Euractiv. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Euractiv →